Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Maya, Ouzegdouh"'
Autor:
Nathalie Forgeard, Marine Baron, Jonathan Caron, Clementine Boccon-Gibod, Daphne Krzisch, Nayara Guedes, Veronique Morel, Nathalie Jacque, Maya Ouzegdouh, Sylvain Choquet, Clotilde Bravetti, Florence Nguyen-Khac, Elise Chapiro, Veronique Leblond, Damien Roos-Weil
Publikováno v:
Haematologica, Vol 107, Iss 11 (2022)
Externí odkaz:
https://doaj.org/article/8e39d02f05074da4ab905ed5259c5b64
Publikováno v:
Journal of clinical apheresisREFERENCES. 37(1)
BACKGROUND The off-line extracorporeal photopheresis (ECP) procedure requires photosensitization in an external cell therapy laboratory as per the French regulatory requirement. This regulation results in higher time and costs compared with the on-li
Publikováno v:
Journal of Clinical Apheresis
Introduction The Pitie Salpetriere Hospital Hemobiotherapy Department, Paris, France, has been providing extracorporeal photopheresis (ECP) since November 2011, and started using the Therakos® CELLEX® fully integrated system in 2012. This report su
Autor:
Alain Delmer, Sylvain Choquet, Maya Ouzegdouh, Marouanne Boubaya, Steven Le Gouill, Olivier Tournilhac, Brigitte Pégourié-Bandelier, Laetitia Souchet, Vincent Levy, Jehan Dupuis, Jerome Tamburini, Jacques Vargaftig, Véronique Leblond
Publikováno v:
American Journal of Hematology. 91:782-786
Waldenstrom's macroglobulinemia is generally treated with alkylating agents, purine analogs and monoclonal antibodies, alone or in combination. We report the outcomes of 82 patients (median age 61 years) treated with the RFC combination. Twenty-five
Autor:
Véronique Morel, Damien roos Weil, Nathalie Jacque, Adrien Grenier, Aurélie Kas, Suella Martino, Olivier Lucidarme, Choquet Sylvain, Maya Ouzegdouh Ouarab, Laurent Garderet, Driss Kharroubi-Lakouas, Veronique Leblond
Publikováno v:
Blood. 136:12-12
Introduction Low-dose CT scans and magnetic resonance imaging (MRI) using T2- and T1-weighted contrasted enhanced images are the standard methods of bone staging for newly diagnosed and relapsed multiple myeloma (MM) patients. Fluoro-desoxy-glucose p
Autor:
Aurore Caumont-Prim, Doumit Chahwan, Pascal Chaibi, Paul Legendre, Mélisande Le Jouan, Guillaume Morelle, Olivier Hermine, François Montestruc, Yasmine Hassani, Jean-Emmanuel Kahn, Isabelle Durand-Zaleski, Luc Mouthon, Marguerite Vignon, Zora Marjanovic, Marie Darrodes, Bertrand Godeau, Olivier Lortholary, Maya Ouzegdouh
Publikováno v:
Clinical Immunology. 215:108419
Introduction We conducted a retrospective multicenter cohort study of patients receiving Immunoglobulin replacement therapy (IgRT) for secondary immune deficiency (SID) during 2012. Methods Data were retrospectively collected from the first dose of I
Autor:
Julie Lejeune, Carole Soussain, Xavier Leleu, Brigitte Dreyfus, Caroline Dartigeas, Véronique Leblond, Stéphane Leprête, Sylvie Chevret, Marie-Sarah Dilhuidy, Anne Banos, Thérèse Aurran, Brigitte Pegourie, Olivier Tournilhac, Herve Oya, Beatrice Mahe, Bruno Anglaret, Caroline Besson, Anne Vekhoff, Pierre Morel, Maya Ouzegdouh
Publikováno v:
Leukemia & lymphoma
Leukemia & lymphoma, Taylor & Francis, 2017, 58 (11), pp.2615-2623. ⟨10.1080/10428194.2017.1307357⟩
Leukemia & lymphoma, Taylor & Francis, 2017, 58 (11), pp.2615-2623. 〈10.1080/10428194.2017.1307357〉
Leukemia & lymphoma, 2017, 58 (11), pp.2615-2623. ⟨10.1080/10428194.2017.1307357⟩
Leukemia & lymphoma, Taylor & Francis, 2017, 58 (11), pp.2615-2623. ⟨10.1080/10428194.2017.1307357⟩
Leukemia & lymphoma, Taylor & Francis, 2017, 58 (11), pp.2615-2623. 〈10.1080/10428194.2017.1307357〉
Leukemia & lymphoma, 2017, 58 (11), pp.2615-2623. ⟨10.1080/10428194.2017.1307357⟩
In patients with advanced Waldenström macroglobulinemia (WM), overall response rate (ORR) and median progression-free survival (PFS) achieved with bortezomib alone and bortezomib rituximab combination were 27-85% and 7.9 months, and 81% and 16.4 mon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f17c36bc619884109a0b417760710e1
https://hal.archives-ouvertes.fr/hal-01655961
https://hal.archives-ouvertes.fr/hal-01655961
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of clinical apheresis. 33(1)
Plerixafor (Mozobil) in combination with granulocyte colony-stimulating factor (G-CSF) has shown to increase mobilization of peripheral blood stem cells (PBSC) as compared to G-CSF alone in patients undergoing autologous stem cell transplantation (AS
Autor:
Sabbah, Mohamed1, Nguyen, Stephanie1, Ouzegdouh, Maya1, Choquet, Sylvain1, Buob, David2, Boffa, Jean Jacques3, Cez, Alexandre3, Garderet, Laurent1 laurent.garderet@aphp.fr
Publikováno v:
American Journal of Case Reports. 11/1/2024, Vol. 25, p1-5. 5p.